NEW YORK ( TheStreet) -- DexCom (Nasdaq: DXCM) hit a new 52-week low Tuesday as it is currently trading at $7.32, below its previous 52-week low of $7.33 with 136,010 shares traded as of 10:40 a.m. ET. Average volume has been 656,900 shares over the past 30 days.

DexCom has a market cap of $515.1 million and is part of the health care sector and health services industry. Shares are down 44.1% year to date as of the close of trading on Monday.

DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States.
  • Practice your DXCM trading strategies and win cash in our stock game.

TheStreet Ratings rates DexCom as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full DexCom Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

These Are the Biggest Winners and Losers in Activist Investing This Year

These Are the Biggest Winners and Losers in Activist Investing This Year

Fundamentals Drive This Rally: Cramer's 'Mad Money' Recap (Thursday 11/16/17)

Fundamentals Drive This Rally: Cramer's 'Mad Money' Recap (Thursday 11/16/17)

Comcast, Lululemon, EQT and Other New Activist Investments

Comcast, Lululemon, EQT and Other New Activist Investments

The Case for the Bears: Cramer's 'Mad Money' Recap (Wed 10/4/17)

The Case for the Bears: Cramer's 'Mad Money' Recap (Wed 10/4/17)

Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus

Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus